436 related articles for article (PubMed ID: 15203192)
1. Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells.
Daou GB; Srivastava AK
Free Radic Biol Med; 2004 Jul; 37(2):208-15. PubMed ID: 15203192
[TBL] [Abstract][Full Text] [Related]
2. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
Bouallegue A; Vardatsikos G; Srivastava AK
Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
4. ET-1-induced growth promoting responses involving ERK1/2 and PKB signaling and Egr-1 expression are mediated by Ca2+/CaM-dependent protein kinase-II in vascular smooth muscle cells.
Bouallegue A; Simo Cheyou ER; Anand-Srivastava MB; Srivastava AK
Cell Calcium; 2013 Dec; 54(6):428-35. PubMed ID: 24238620
[TBL] [Abstract][Full Text] [Related]
5. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
Azar ZM; Mehdi MZ; Srivastava AK
Can J Physiol Pharmacol; 2006 Jul; 84(7):777-86. PubMed ID: 16998541
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of Ca2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells.
Blanc A; Pandey NR; Srivastava AK
Antioxid Redox Signal; 2004 Apr; 6(2):353-66. PubMed ID: 15025937
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells.
Kapakos G; Youreva V; Srivastava AK
Can J Physiol Pharmacol; 2012 Sep; 90(9):1277-85. PubMed ID: 22913328
[TBL] [Abstract][Full Text] [Related]
9. CaMKII knockdown attenuates H2O2-induced phosphorylation of ERK1/2, PKB/Akt, and IGF-1R in vascular smooth muscle cells.
Bouallegue A; Pandey NR; Srivastava AK
Free Radic Biol Med; 2009 Sep; 47(6):858-66. PubMed ID: 19545622
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
Meng D; Shi X; Jiang BH; Fang J
Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
[TBL] [Abstract][Full Text] [Related]
11. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
Walcher D; Babiak C; Poletek P; Rosenkranz S; Bach H; Betz S; Durst R; Grüb M; Hombach V; Strong J; Marx N
Circ Res; 2006 Nov; 99(11):1181-7. PubMed ID: 17068290
[TBL] [Abstract][Full Text] [Related]
12. Enhanced levels of endogenous endothelin-1 contribute to the over expression of Giα protein in vascular smooth muscle cells from SHR: Role of growth factor receptor activation.
Gomez Sandoval YH; Anand-Srivastava MB
Cell Signal; 2011 Feb; 23(2):354-62. PubMed ID: 20959139
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species mediate ET-1-induced activation of ERK1/2 signaling in cultured feline esophageal smooth muscle cells.
Song HJ; Kim JS; Lee MJ; Nam YS; Sohn UD
Arch Pharm Res; 2007 Sep; 30(9):1080-7. PubMed ID: 17958324
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.
Tanimoto T; Lungu AO; Berk BC
Circ Res; 2004 Apr; 94(8):1050-8. PubMed ID: 15044318
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration.
Weber DS; Taniyama Y; Rocic P; Seshiah PN; Dechert MA; Gerthoffer WT; Griendling KK
Circ Res; 2004 May; 94(9):1219-26. PubMed ID: 15059930
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
Motobayashi Y; Izawa-Ishizawa Y; Ishizawa K; Orino S; Yamaguchi K; Kawazoe K; Hamano S; Tsuchiya K; Tomita S; Tamaki T
Hypertens Res; 2009 Mar; 32(3):188-93. PubMed ID: 19262481
[TBL] [Abstract][Full Text] [Related]
17. Early Growth Response Protein-1 Expression by Insulin-Like Growth Factor-1 Requires ROS-Dependent Activation of ERK1/2 and PKB Pathways in Vascular Smooth Muscle Cells.
Youreva V; Srivastava AK
J Cell Biochem; 2016 Jan; 117(1):152-62. PubMed ID: 26084532
[TBL] [Abstract][Full Text] [Related]
18. PYK2/CAKbeta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells.
Frank GD; Motley ED; Inagami T; Eguchi S
Biochem Biophys Res Commun; 2000 Apr; 270(3):761-5. PubMed ID: 10772898
[TBL] [Abstract][Full Text] [Related]
19. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Li PG; Xu JW; Ikeda K; Kobayakawa A; Kayano Y; Mitani T; Ikami T; Yamori Y
Hypertens Res; 2005 Apr; 28(4):369-77. PubMed ID: 16138568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
